Variant report
Variant | esv3382764 |
---|---|
Chromosome Location | chr11:93792354-93794452 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:93792254-93792598 | K562 | blood: | n/a | chr11:93792416-93792427 |
2 | CEBPB | chr11:93792392-93792470 | H1-hESC | embryonic stem cell: | n/a | chr11:93792416-93792427 |
3 | CEBPB | chr11:93792264-93792594 | IMR90 | lung: | n/a | chr11:93792416-93792427 |
4 | CEBPB | chr11:93792246-93792559 | HepG2 | liver: | n/a | chr11:93792416-93792427 |
5 | CEBPB | chr11:93793593-93793911 | IMR90 | lung: | n/a | n/a |
6 | CEBPB | chr11:93792267-93792587 | A549 | lung: | n/a | chr11:93792416-93792427 |
7 | CTCF | chr11:93794160-93794310 | NHEK | skin: | n/a | n/a |
8 | FOS | chr11:93791883-93792464 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr11:93793595-93793869 | MCF10A-Er-Src | breast: | n/a | chr11:93793846-93793858 |
10 | FOS | chr11:93793529-93793929 | MCF10A-Er-Src | breast: | n/a | chr11:93793846-93793858 |
11 | STAT3 | chr11:93794161-93794202 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr11:93793562-93793840 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227593 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375230830 | chr11:93792404-93792405 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs535716565 | chr11:93792432-93792433 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs553720023 | chr11:93792433-93792434 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs112344155 | chr11:93792464-93792465 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs983329 | chr11:93792471-93792472 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs565883911 | chr11:93792501-93792502 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186595101 | chr11:93792636-93792637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34139237 | chr11:93792652-93792653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558286762 | chr11:93792661-93792662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576567907 | chr11:93792713-93792714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190770397 | chr11:93792719-93792720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111294307 | chr11:93792759-93792760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374306565 | chr11:93792775-93792776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs367861333 | chr11:93792819-93792820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11020644 | chr11:93792858-93792859 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs553657927 | chr11:93792859-93792860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574281263 | chr11:93792875-93792876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573200194 | chr11:93792888-93792889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541724792 | chr11:93792901-93792902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs983328 | chr11:93792937-93792938 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs983327 | chr11:93792947-93792948 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs138429645 | chr11:93793026-93793027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2460043 | chr11:93793064-93793065 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs531301957 | chr11:93793104-93793105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183014624 | chr11:93793106-93793107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2460042 | chr11:93793135-93793136 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs368083406 | chr11:93793206-93793207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369505196 | chr11:93793225-93793226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369866058 | chr11:93793260-93793261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201609757 | chr11:93793296-93793297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112450930 | chr11:93793315-93793316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528849924 | chr11:93793323-93793324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547692493 | chr11:93793345-93793346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565789962 | chr11:93793381-93793382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191153359 | chr11:93793392-93793393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199942339 | chr11:93793402-93793403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554155514 | chr11:93793418-93793419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570346265 | chr11:93793419-93793420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569747456 | chr11:93793437-93793438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1518558 | chr11:93793440-93793441 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs572779119 | chr11:93793451-93793452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112396301 | chr11:93793460-93793461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570213100 | chr11:93793462-93793463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369152736 | chr11:93793469-93793470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116249419 | chr11:93793483-93793484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573998949 | chr11:93793486-93793487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369143183 | chr11:93793520-93793521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534661662 | chr11:93793567-93793568 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs1518557 | chr11:93793577-93793578 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs571008719 | chr11:93793591-93793592 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 18852474 | CNVD |
Breast cancer | 22844521 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93780200-93793800 | Weak transcription | Fetal Intestine Large | intestine |
2 | chr11:93789200-93793800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr11:93789200-93793800 | Weak transcription | Aorta | Aorta |
4 | chr11:93791400-93794800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr11:93791400-93794800 | Enhancers | NHEK | skin |
6 | chr11:93791600-93792600 | Enhancers | HMEC | breast |
7 | chr11:93791800-93793600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr11:93792600-93793600 | Weak transcription | HMEC | breast |
9 | chr11:93793600-93794800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr11:93793600-93794800 | Enhancers | HMEC | breast |
11 | chr11:93793800-93794600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr11:93793800-93794600 | ZNF genes & repeats | Aorta | Aorta |
13 | chr11:93793800-93794600 | Enhancers | Fetal Intestine Large | intestine |
14 | chr11:93794200-93794600 | Enhancers | Fetal Intestine Small | intestine |